Drug Profile
Candida vaccine
Latest Information Update: 05 Jan 2000
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Fungal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Candidiasis
Most Recent Events
- 05 Jan 2000 No-Development-Reported for Candidiasis in Israel (Parenteral)
- 10 Apr 1997 New profile
- 10 Apr 1997 Preclinical development for Candidiasis in Israel (Parenteral)